Apple Responds to ITC Orders
Tech giant Apple recently announced that it will cease sales of two of its latest Apple Watch models, the Apple Watch Series 9 and Apple Watch Ultra 2. The products will no longer be available for purchase on Apple’s website from Thursday, with in-store sales discontinuing from Sunday. However, Apple will continue to offer older models to consumers.
This decision comes as a response to the International Trade Commission’s (ITC) orders issued in October. The ITC found that the blood oxygen sensor on the Apple Watch infringed upon intellectual property owned by Masimo, a leading medical technology company catering to hospitals.
Appeal Denied by ITC
Apple’s attempt to stay the original decision while appealing it was denied by the ITC on Wednesday. This means that Apple will be closer to being restricted from selling one of its flagship products in its largest market during a peak sales period for the company.
As a result of this development, Apple’s shares have seen a slight decrease of less than 1% since the announcement was made.
White House Monitoring the Case
The White House is closely monitoring the situation. Press secretary Karine Jean-Pierre commented on Tuesday that they are tracking the case and the upcoming December 25 deadline. She further informed reporters that the U.S. Trade Representative, Ambassador Katherine Tai, has been entrusted with the authority to make determinations regarding this matter. Ambassador Tai is said to be carefully assessing all factors related to the case.
Allegations of Deception
In addition to the infringement claims made against Apple, Masimo CEO Joe Kiani has accused the tech giant of deceptive practices. Kiani alleges that Apple engaged in acquisition and partnership discussions while simultaneously poaching Masimo’s technical staff. Despite Kiani extending an olive branch and offering to collaborate in the interest of shareholders and the public, Apple did not respond.
This legal battle has significant implications for both Apple and Masimo and is one worth closely monitoring in the coming weeks.